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Lactobacilli prevent overproduction of pathogenic microorganisms and contribute protecting vaginal 
microbiota. Many probiotic microorganisms are categorized as Lactic Acid Bacteria. In this study, it 
was aimed identifying probiotic characteristics of Lactobacillus crispatus isolated from the vagina of 
a healthy woman. For this purpose, lactic acid, hydrogen peroxide and proteolytic activity quantities 
and auto-aggregation, co-aggregation and hydrophobicity abilities of Lactobacillus crispatus, which 
has been isolated and identified by 16s rRNA sequence analysis, were determined. Additionally, bile 
salt and acid resistance, along with antibiotic susceptibility of Lactobacillus crispatus were analyzed by 
the end of 3 hours. Lactic acid, hydrogen peroxide and proteolytic activity quantities of Lactobacillus 
crispatus were measured 2.275%, 0.334±0.075 µg/mL and 2.131±0,000 mg/mL respectively. The findings 
include existence of co-aggregation and auto-aggregation ability, but not hydrophobicity. By the end 
of 3 hours, the viability was preserved in 0.1% and 0.3% bile salt medium and, at pH 3. L. crispatus 
exhibited resistance to methicillin, metronidazole, oxacillin, and sulfamethoxazole + trimethoprim, but 
the bacteria exhibited susceptibility to tested the other antibiotics. This study will make an important 
contribution to the literature about probiotic characteristics of L. crispatus and our strain isolated from 
the vagina might be considered as a candidate probiotic. 
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INTRODUCTION
Lactobacilli are normal inhabitants of vaginal of 
healthy women. Vaginal fluid contains 1010 Lactobacillus 
spp. per mL (Redondo-Lopez, Cook, Sobel, 1990). Albert 
S. Döderlein, a German physician, described bacterium 
isolated from a pregnant woman’s vagina as Döderlein 
bacillus (Lepargneur, Rousseau, 2002).
Vaginal microbiota has a critical role in preserving 
urogenital health (Jespers et al., 2012). Lactobacilli 
prevent overproduction of pathogenic microorganisms 
and contribute protecting vaginal microbiota. Lactobacilli 
in the vagina compete with the pathogens in order to 
prevent them adhere to epithelial cells (Kaewnopparat et 
al., 2013). Previous studies suggested that Lactobacillus 
species bind to host epithelial cell receptors to block 
attachment of various urogenital pathogens including 
Group B Streptococcus species, Staphylococcus 
aureus, Gardnerella vaginalis, Neisseria gonorrhoeae, 
Pseudomonas aeruginosa, and Klebsiella pneumoniae to 
epithelial cells (Fettweis et al., 2012).
FAO/WHO descr ibed  prob io t ics  as  “ l ive 
microorganisms which when administered in adequate 
amounts confer a health benefit to the host” in 2001 (FAO/
WHO, 2001). Many probiotic microorganisms including 
Lactobacillus sp., Bifidobacterium sp., and Enterococcus 
sp. are categorized as Lactic Acid Bacteria (LAB) 
(Bergonzelli et al., 2005). Probiotic microorganisms have 
been suggested as candidate microorganisms to be included 
in probiotics for vaginal use (Shah, 2007). Probiotic 
effect is strain-specific (Paolillo et al., 2009). Therefore, 
it is important to establish the probiotic properties of 
lactic acid bacteria before the bacteria is developed as a 
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probiotic product. In this study, it was aimed identifying 
probiotic characteristics of Lactobacillus crispatus 
isolated from the vagina of a healthy woman. For this 
purpose, lactic acid, hydrogen peroxide and proteolytic 
activity quantities and auto-aggregation, co-aggregation 
and hydrophobicity abilities of Lactobacillus crispatus, 
which has been isolated and identified by 16s rRNA 
sequence analysis, were determined. Additionally, bile 
salt and acid resistance, along with antibiotic susceptibility 
of Lactobacillus crispatus were analyzed by the end 
of 3 hours. There are not many studies in the literature 
regarding the investigation of the probiotic properties 
of L. crispatus isolated from the vagina, so the work we 
have done will be a guide to L. crispatus and will greatly 
contribute to the literature.
MATERIAL AND METHODS
Bacteria isolation 
In this study, bacteria isolated from the vagina of a 
healthy woman was inoculated with de Man, Rogosa, and 
Sharpe (MRS) agar) and incubated for 48 hours at 37°C 
5% CO2. Following incubation, gram staining and catalase 
test were performed. The bacteria isolate was stored in 
25% glycerol, at -80°C. 
This study was approved by İstanbul Medipol 
University Non-Interventional Clinical Researches Ethics 
Board on 11/04/2013 with decision number 38. This work 
was supported by a grant from the Anadolu of University 
and Research, within the research project 1305F089 / 
2016. In this project, samples were taken from vaginal 
smear of 30 pre-menopausal healthy women between 
20-40 years of age. It was also taken into consideration 
that women did not use antibiotics until the last 2 months.
Genotypic identification of bacteria with 16s 
rRNA sequence analysis 
16s rRNA sequence analysis was performed 
genotypic identification of the bacteria isolate. The 
genomic DNA of the isolate was purified using GeneJET 
genomic DNA purification kit (ThermoFischer Scientific). 
Obtained genomic DNA was used as template DNA and 
PCR reaction was performed for 16s rRNA gene locus. 
27F 5’-AGAGTTTGATCMTGGCTCAG-3’ and 1492R 
5’TACGGYTACCTTGTTACGACTT-3’ universal 
primers were used. PCR reaction components include 
2.5 µL of 10X TaqBuffer ( + KCl-MgCl2), 2.5 µL of 25 mM 
MgCl2, 2.5 µL of 2.5 mM dNTP mix, 2.5 µL of 2.5 mM 
27F primer, 2.5 µL of 2.5 mM 1492R primer, 0.25 µL of 
Taq polymerase (5 u/ µL), 11.75 µL nuclease-free ddH2O 
and 1 µL of template DNA. PCR products obtained from 
the reaction were screened in 1% agarose gel. 1492R and 
907R (5’-CCGTCAATTCMTTTRAGTTT-3’) primers 
were used for the sequence analysis of nearly 1400 base 
pair region (Doi et al., 2013). The sequence analysis of 
isolate was performed by MedSanTek Laboratory Supplies 
Trade & Industry Ltd. 
Lactic acid production assay
The LAB isolate was incubated in the MRS 
broth medium at 37°C 5% CO2 for 48 hours. Following 
incubation, 1 mL of fresh LAB culture was transferred to 
a clean flask and filled up to 100 mL by sterile dH2O. 2-3 
drops of phenolphthalein indicator were added and titrated 
with 0.1 M NaOH solution. The amount of NaOH was 
recorded. Acid produced by the culture was calculated as 
percent titrable acidity. Lactic acid amount that the bacteria 
produced was calculated by the formula below. The study 
was conducted in duplicate (Demirci, Gündüz, 1994).
Acidity %: 0.1 N NaOH (mL) amount used × 0.9/mL
Hydrogen peroxide production assay
The LAB isolate was incubated in the MRS 
broth medium at 37°C 5% CO2 for 48 hours. Following 
incubation, 5 mL of dH2O was added to LAB culture and 
centrifuged at 5000 x rpm for 15 minutes. The supernatant 
phase following centrifugation was filtered through 
Whatman no 42 filter paper. 4 mL of filtrate obtained 
from filtering process was transferred to a tube. 0.5 mL 
sulfuric acid, 0.5 mL ammonium molybdate and 0.5 mL 
potassium iodide were added to the filtrate respectively 
and mixed thoroughly after each chemical addition. 
Optical density (OD) was measured by 350 nm wavelength 
spectrophotometer for 3 times (Shimadzu, UV-1800). 
OD values were converted into μg/mL formulation based 
on standard curve adjusted previously. The study was 
conducted in duplicate (Patrick, Wagner, 1949).
Proteolytic activity assay 
The LAB isolate was incubated in 5 mL non-fat milk 
liquid medium at 37°C 5% CO2 for 48 hours. Following 
incubation, 1 mL of dH2O and 10 mL of trichloroacetic 
acid (TCA) were added to the medium respectively, 
mixed gently, incubated at room temperature for 10 
minutes and filtered through Whatman no 1 filter paper. 
2.5 mL of the filtrate was transferred to a separate tube, in 
which 5 mL of Na2CO3.Na4P2O7 solution was added and 
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mixed thoroughly. 1.5 mL of phenol indicator was added 
and shaken until dark blue color appears. The sample 
was centrifuged at 8000 x rpm for 15 minutes. OD of 
the supernatant was measured by 650 nm wavelength 
spectrophotometer for 3 times and the values were 
recorded, which were converted into μg/mL formulation 
based on standard curve adjusted for proteolytic activity. 
The study was conducted in duplicate (Kıvanç, Yapıcı, 
2015). 
Auto-aggregation 
The LAB isolate was incubated in the MRS 
broth medium at 37°C 5% CO2 for 48 hours. Following 
incubation, the final concentration was adjusted to 
108 colony forming unit (cfu)/mL with McFarland 
Densitometer (DEN-1, Biosan) using phosphate buffer 
saline (PBS) with pH 6.2. Microbial suspension was 
spread on a microscope slide and observed by light 
microscope (Leica DM500) with 100x magnification. 
Auto-aggregation test is considered positive if the cells 
aggregate within 2 minutes. The results were recorded 
(Pascual et al., 2008).
Co-aggregation
In this assay, Escherichia coli ATCC 25922 
strain was used as test microorganism. The incubation 
conditions for the LAB isolate was in the MRS broth 
medium at 37°C 5% CO2 for 48 hours and for E. coli 
ATCC 25922 in brain-heart infusion broth (BHI) medium 
at 37°C for 24 hours. Following incubation, the LAB 
isolate and E. coli ATCC 25922 adjusted to 108 cfu/mL 
with McFarland Densitometer (DEN-1, Biosan) in the 
PBS were transferred to a separate tube and mixed for 
15 seconds. Samples from both bacteria were seeded in 
a 24-well plate and incubated at 37°C for 48 hours while 
shaking gently. Following incubation, samples were taken 
from each well, Gram stained and samples were examined 
under light microscope (Leica DM500). Co-aggregation 
condition of the LAB isolate with E. coli ATCC 25922 was 
recorded (Pascual et al., 2008).
Hydrophobicity
The LAB isolate was incubated in the MRS broth 
medium at 37°C 5% CO2 for 48 hours. Following 
incubation, the LAB culture were centrifuged at 12000 
x g, 5°C for 5 minutes, washed twice in 0.05 M K2HPO4 
(pH: 6.5) buffer and finally solved in the same buffer. 
The cell suspension was adjusted to an A560 nm value 
(Shimadzu, UV-1800) of 1.0 with the buffer and 3 mL of 
the bacterial suspension is transferred to a separate tube. 
0.6 mL of n-hexadecane was added in the tube and mixed 
for 120 seconds. The two phases were allowed to separate 
for 0 h at 37°C. The aqueous phase was carefully removed 
and spectrophotometric measurement was performed on 
A560 nm (Vinderola, Reinheimer, 2003). 
Hydrophobicity was calculated by the formula 
below:
%= (A0 -A)A0 x 100
A0: Initial absorbance value; A: Final absorbance value
Identifying acid resistance
The LAB isolate was incubated in the MRS broth 
medium at 37°C 5% CO2 for 48 hours. Following 
incubation, the LAB culture were inoculated with the MRS 
broth, in which pH was adjusted to 2 and 3 by 1 mol/L HCl. 
The MRS broth with pH 7.2 was used as control group. 
Following incubation, samples were collected at 0, 1, 2 and 
3-hour time points, diluted serially and 10 µL from each 
sample was inoculated on the petri dishes containing the 
MRS agar. Petri dishes were incubated at 37°C 5% CO2 
for 48 hours. Following incubation, colonies in the petri 
dishes were counted and results were recorded as cfu/mL 
(Claire et al., 2006).
Identifying bile salt resistance
The LAB isolate was incubated in the MRS broth 
medium at 37°C 5% CO2 for 48 hours. Following 
incubation, the LAB culture was inoculated with the 
MRS broth medium containing 0.1% and 0.3% bile salt. 
Bile salt free-MRS broth medium was used as control. 
Following incubation, samples were collected at 0, 1, 2 and 
3-hour time points, diluted serially and 10 µL from each 
sample was inoculated on the petri dishes containing the 
MRS agar. Petri dishes were incubated at 37°C 5% CO2 
for 48 hours. Following incubation, colonies in the petri 
dishes were counted and results were recorded as cfu/mL 
(Pereira, Gibson, 2002).
Antibiotic susceptibility
Disc Diffusion Susceptibility Method was applied in 
order to clarify antibiotic susceptibility of the LAB isolate 
to various antibiotics. In this study, total of 12 antibiotics 
including ampicillin, erythromycin, gentamycin, 
clindamycin, methicillin, metronidazole, oxacillin, 
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penicillin, cephalothin, sulfamethoxazole + trimethoprim, 
tetracycline and vancomycin were tested. The LAB isolate 
incubated on the MRS agar medium at 37°C 5% CO2 for 48 
hours was adjusted to 0.5 McFarland Turbidity Standard 
(108 cfu/mL) in the 0.85% physiological saline. Microbial 
suspension was inoculated on Mueller Hinton Agar 
medium using a swab. Cultured petri dishes were dried 
for 15 minutes. Antibiotic discs were taken by forceps and 
placed on surface of petri dish under aseptic conditions. 
15 minutes later, they were incubated at 37°C 5% CO2 
for 24 to 48 hours. Zone diameters around the discs were 
measured, recorded and the results were evaluated. The 
study was conducted in duplicate (Kaewnopparat et al., 
2013). 
RESULTS 
Gram staining and catalase test were performed on 
the isolate obtained from the vagina of a healthy woman. 
The isolate Gram-positive had catalase-negative activity. 
Genotypic identification through 16s rRNA sequence 
analysis suggested that the isolate was Lactobacillus 
crispatus (Accession number: LC065039.1) with 99% 
similarity. 
Lactic acid production, hydrogen peroxide 
production and proteolytic activity of the isolate were 
recorded as 2.275%, 0.334±0.075 µg/mL and 2.131±0,000 
mg/mL respectively (Table I). Although the isolate had 
auto-aggregation and co-aggregation activity, it had not 
hydrophobicity activity (Table II). By the end of 3-hour 
period, the bacteria protected its viability on the 0.1% and 
0.3% bile salt conditions and, at pH 3 (Figure I). 
The acid and bile salt resistance of L. crispatus were 
determined by colony counting at the end of 0th, 1st, 2nd 
and 3rd hours. h:hour.
The zone diameters around the antibiotic discs 
(ampicillin, erythromycin, gentamycin, clindamycin, 
penicillin, cephalothin, tetracycline and vancomycin 
discs) were recorded as 36mm, 36 mm, 24 mm, 38 mm, 
38 mm, 38 mm, 30 mm and 24 mm, respectively. Zone 
formation around methicillin, metronidazole, oxacillin and 
sulfamethoxazole + trimethoprim discs was not observed.
DISCUSSION
Lactobacillus species have beneficial effects 
predominate in the vaginal microbiota of healthy 
women. These bacteria are very important in terms of 
vaginal ecosystem health protection (Aroutcheva et 
al., 2001). Lactobacillus species are catalase negative, 
FIGURE 1 - Acid and bile salt resistances of L. crispatus.
TABLE I - The amounts of lactic acid, hydrogen peroxide and proteolytic activity of the L. crispatus
% of Acidity The amount of hydrogen peroxide (µg / mL) Proteolytic activity (mg/mL)
2.275% 0.334±0.075 2.131±0.000
L. crispatus was incubated in the MRS broth medium at 37°C 5% CO2 for 48 hours. Acid produced by the isolate was calculated 
as percent titrable acidity. The amount of hydrogen peroxide and proteolytic activity of the isolate were determined by 
spectrophotometrically. The tests were conducted in duplicate.
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oxidase negative, gram positive, bacil shaped, facultative 
aerotolerant, immobilized and non-spore forming bacteria 
(Hanghshenas et al., 2014).
Previous studies reported that lactic acid bacteria 
including Lactobacillus acidophilus, L. plantarum, L. 
casei, L. cellobiotus, L. oris, L. reuteri, L. ruminis, L. 
salivarius, L. brevis, L. delbrueckii, L. vaginalis, L. 
gasseri, and L. crispatus are isolated from the vagina of 
healthy women (Atassi et al., 2006; Kıvanç, Yazıcıoğlu, 
Dinçer, 2011). In this study, we had isolated L. crispatus 
from a healthy woman’s vagina. 
Lactic acid bacteria protect the vagina from 
pathogens by producing antimicrobials such as lactic acid 
and bacteriocin (Redondo-Lopez, Cook, Sobel, 1990). The 
vaginal homeostasis is preserved by lactic acid production 
of the LABs in the vagina. By the production of organic 
acids such as lactic acid, vaginal pH is kept below 4.5. 
By the acidic nature of the vaginal, the development of 
pathogen microorganisms is prevented. (Cheeti, Warrier, 
Lee, 2006). In a study conducted by Aslim and Kilic in 
2006, it was revealed that the amount of acidity in L. 
crispatus strains isolated from healthy women vaginal 
was 0.48-0.85% (Aslim, Kilic, 2006). In our study, we 
monitored that lactic acid production rate of isolated L. 
crispatus was 2.275%. 
In vitro experiments indicated that H2O2 suppress 
development of endogenous pathogens and various 
pathogen microorganisms including G. vaginalis and 
HIV (Jespers et al., 2012). In a study conducted by Aslim 
and Kilic in 2006, it was revealed that although some of 
L. crispatus strains isolated from healthy women vagina 
did not produced H2O2, although some of the L. crispatus 
strains produced 1.24±0.02 µg/mL - 3.84±0.04 µg/mL 
of H2O2 (Aslim, Kilic, 2006). Abramov et al. reported 
that L. crispatus 2029 isolated from the healthy women 
vagina produced 0.120±0.05 µg/mL of H2O2 (Abramov 
et al., 2014). We showed that L. crispatus isolated 
from the vagina produced 0.334±0.075 µg/mL of H2O2. 
Additionally, L. crispatus’ proteolytic activity amount was 
found 2.131±0.000 mg/mL. There hasn’t been found any 
study about proteolytic activity of L. crispatus isolated 
from the vagina.
Autoaggregation and coaggregation activities of 
lactic acid bacteria have great importance (Jankovic et 
al., 2003). Kmet and Lucchini have shown that 12 of the 
60 lactic acid bacteria isolated from vagina have auto-
aggregation activity (Kmet, Lucchini, 1997). In our study, 
we found that L. crispatus has auto-aggregation activity. 
It has been reported that Lactobacillus species also have 
co-aggregation activity with pathogenic bacteria (Reniero 
et al., 1991). It is clear that they are able to aggregate 
and co-aggregate with uropathogenic E. coli. Kmet and 
Lucchini have shown that only 3 of 60 lactic acid bacteria 
isolated from vagina have co-aggregation activity with 
E. coli strains (Kmet, Lucchini, 1997). Our results also 
indicated that L. crispatus did not co-aggregate with E. 
coli ATCC 25922. 
One of the most important features of probiotics 
is that microorganisms are resistant to low pH and high 
bile salts (Brink et al., 2006). Probiotics should be able to 
tolerate certain conditions such as high bile salt (0.3%) and 
low pH (2 - 3) for a minimum of 90 minutes (Hanghshenas 
et al., 2014). It has been demonstrated that L. crispatus 
preserved its viability by the end of 3-hour period at pH 3 
in our study. Previous studies showed that Lactobacillus 
crispatus ATCC 33820 strain does not survive more than 
2 hours at pH 2 (Pereira, Gibson, 2002). 
Bile salts have been reported to be toxic to bacterial 
cells because of disrupting organization of the cell 
membrane. Lactic acid has to produce bile salt to survive 
in the small intestine (Succi et al., 2005). In a study 
conducted, it was revealed that Lactobacillus lactis 
ATCC 11454, L. paracasei ATCC 27092, L. casei ATCC 
393 ve L. rhamnosus ATCC 53103 strains were able to 
maintain their viability at the end of the 3rd hour in 0.4% 
bile salt solution (Kaewnopparat et al., 2013). Moreover, 
L. fermentum SK5 strain can survive in 0.1% and 0.2% 
bile salt conditions (Succi et al., 2005). In our study, we 
revealed that L. crispatus could maintain its viability in 
0.1% and 0.3% bile salt conditions at the end of the 3rd 
hour. Besides, our results indicate that L. crispatus did not 
exhibit hydrophobicity. 
In this study, antibiotic susceptibility of L. crispatus 
investigated with disc diffusion method. Total of 12 
antibiotics, namely ampicillin, erythromycin, gentamycin, 
clindamycin, methicillin, metronidazole, oxacillin, 
penicillin, cephalothin, sulfamethoxazole + trimethoprim, 
tetracycline and vancomycin were tested. Test results 
TABLE II - The auto-aggregation, co-aggregation and 
hydrophobicity activities of the L. crispatus
Auto-aggregation Co-aggregation Hydrophobicity
(+) (+) (-)
(+): positive (-): negative. Auto-aggregation of L. crispatus was 
examined microscopically (Leica DM500). Auto-aggregation 
test is considered positive if the cells aggregate within 2 minutes. 
In the co-aggregation assay, E. coli ATCC 25922 strain was used 
as test microorganism. The coaggregation of L. crispatus with E. 
coli ATCC 25922 was examined microscopically. The amount 
of hydrophobicity activity of L. crispatus were determined by 
spectrophotometrically. 
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revealed that L. crispatus showed resistance to methicillin, 
metronidazole, oxacillin, and sulfamethoxazole + 
trimethoprim, yet showed susceptibility to ampicillin, 
erythromycin, gentamycin, clindamycin, penicillin, 
cephalothin, tetracycline and vancomycin. In a study 
conducted by Hütt et al. in 2016, it was revealed that 
all bacteria from 26 L. crispatus strains isolated from 
vagina showed resistance to metronidazole, kanamycin 
ve trimethoprim+sulfamethoxazole, although they 
showed susceptibility to ampicillin, chloramphenicol, 
eriythromycin, gentamycin, nitrofurantoin, tetracycline 
and vancomycin. Metronidazole is one of the most 
commonly used antibiotics in bacterial vaginosis (Ocana, 
Silva, Nader-Mac´ıas, 2006). In our study, it was observed 
that our isolate showed metronidazole resistance in 
agreement with these results. 
It has been reported that strains develop resistance to 
a specific antibiotic may be given with antibiotics during 
antibiotic treatment (Cebeci, Gürakan, 2003). It has been 
reported that antibiotic along with LAB strains that are not 
susceptible to the antibiotic may be given for the protection 
of microbiota during bacterial vaginosis treatment (Ocana, 
Silva, Nader-Mac´ıas, 2006). Thus, it was observed that 
the microbiota could regenerate in a shorter time (Cebeci, 
Gürakan, 2003). 
The normal vaginal microbiota has been found to 
consist primarily of one or more of merely four distinct 
species, in particular L. crispatus, L. jensenii, L. gasseri, 
and L. iners (Verstraelen et al., 2009). Lactobacillus 
crispatus was the most frequent cultured species in 
vaginal samples. Presence of L. crispatus is considered a 
major determinant to the stability of the normal vaginal 
microbiota in women of reproductive age (Hütt et al., 
2016). Besides, L. crispatus appears to be substantially 
prevailing over the other hydrogen peroxide producing 
Lactobacillus species (Abramov et al., 2014). In addition, 
L. crispatus is a lactic acid bacteria that produces the 
highest lactic acid when compared to L. iners, L. jensenii, 
and L. gasseri (Ravel et al., 2011). Lactic acid bacteria 
in the vagina protects vaginal health by producing 
antimicrobial agents such as lactic acid and hydrogen 
peroxide against bacterial pathogens (Hütt et al., 2016). 
Lactic acid bacteria that are used as probiotic are 
beneficial microorganisms (Fuller, 1989). Recently, 
probiotics are widely used in therapeutic preparations 
(Shah, 2007). L. crispatus are potential probiotic (Roy 
et al., 2000). L. crispatus CTV-05 was used as a vaginal 
suppository for healthy women with a history of recurrent 
urinary tract infections (Abramov et al., 2014). This 
study did produce findings that contribute to the probiotic 
characterization of a L. crispatus strain but it is not yet a 
readily marketable probiotic product. Our strain promises 
hope and so further studies are needed to be able to use 
this strain as a probiotic.
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